← Leaderboards
Laura Chow
Benaroya Research Inst At Virginia Mason
$561,064
Attributed
$2,244,254
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $946.1K · FY2019–21$1M$750K$500K$250K$0
'19
'20
'21
Funding mix
By agency
NIH$2,244,254 · 1
By mechanism
R01$2,244,254 · 1
Top collaborators
- Jane Hoyt Buckner3 shared
- Peter S Linsley3 shared
- Erik Wambre3 shared
Most similar at Benaroya Research Inst At Virginia Mason
Same institution · by research overlap
- Jane Hoyt Buckner$93,413,622
- Peter S Linsley$7,467,441
- Gerald T Nepom$318,570,989
- Carmen R Mikacenic$5,918,794
- Jessica A Hamerman$18,083,038
Others in their field
Other Emerging Leaders on “Cohort”
- Leonard Freedman · Leidos Biomedical Research, Inc.$70,225,348
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Julie Ake · National Institute Of Allergy And Infectious Diseases$52,642,120
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Scott Hensley · University Of Pennsylvania$47,346,110
- Susan M Landau · University Of California Berkeley$47,252,026
Research focus
CohortAntigensAllergic DiseaseAdverse EventAntitumor ResponseAutoantigensAntigen-Specific T CellsAutoimmune DiseasesAntigen TargetingAutoimmune ResponsesAutoimmunityAutoreactive T CellBiological MarkersCancer PatientCancer TypeCd8b1 GeneCd8-Positive T-LymphocytesCell CompartmentationCellsCharacteristicsCheckpoint InhibitionCheckpoint TherapyClone CellsCollaborations
Grant awards (3)
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$423,377
R01 · FY2021 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$946,097
R01 · FY2020 · CA
Defining the features of T cell response to tumor and self-antigens as predictors of response to checkpoint therapy$874,780
R01 · FY2019 · CA